Neuropathology
10
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (10)
Cognitive Functioning in Adults With Somatic Diseases and General Population From a Biopsychosocial Perspective
Neuropathological Changes of the Intestinal Wall in Patients With Bowel Evacuation Disorders
Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline?
Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease
Idiopathic Generalized Epilepsy Cognitive and Emotional Profile
Development of a Point of Care System for Automated Coma Prognosis
Artificial Intelligence Neuropathologist
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Prospective Study Evaluating the Interest of Long-term Cardiac Recording in Cerebral Infarction
Assessment of the Prevalence of Small Fiber Peripheral Neuropathy Among Non-diabetic Obese Patients